Statoil floored by the Danish pharmaceutical as Novo Nordisk becomes the largest in the Nordic countries

Wednesday, April 04, 2012
The Danish pharmaceutical company, Novo Nordisk has taken the throne as the Nordic region's largest listed company by market capitalization.

Measured in Danish kroner Novo is now valued at Dkr490 billion, and has passed with the group's Dkr486 billion, writes the Danish newspaper Berlingske.

It is not immediately clear why the suddenly change but several factors are being attributed - as to why Novo's shares climb, but no clear explanation, writes Berlingske.

“We like Novo- situation, but as we have done all the time so I can not point out why you suddenly runs amok with stock groeth this way, says head of Equities Mads Zink at Danske Bank to the Danish news agency, Ritzau Finance.

One reason is that there is a general impact on the Danish stock market today than before.
The Danes have money in their hands, because the salary, dividends, and matured bonds are coming in to the tone of about close to Dkr59 billion.

Novo's shares are perceived as a safe investment, and is often used as a parking lot for cash, according to Berlingske. It is, however, other stocks, so it can not explain why Novo's shares have risen 26 percent so far this year, and over fifty percent in the last six months.

Novo Nordisk is the leader in the treatment of diabetes. The company also offers treatment for haemophilia, and for different types of hormone therapy.
By Scancomark.se Team

What do you think about this article or us? Please leave a comment. Thank you!